CEACAM5 and breast cancer: Work published in 2020 by Cotchim et al. demonstrates the prototype of a multiplex electrochemically mediated immunosensor to detect breast cancer serum antigens CEA, CA153, and CA125 with anti-CEA, anti-CA153, and anti-CA125, respectively (41).